23andMe (MEHCQ) Reaches Agreement for Sale of Business to TTAM Research Institute Jun 13, 2025 04:25PM
Regeneron (REGN) Executive: 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference Jun 9, 2025 11:09AM
Increasing unusual option volume: ME AMKR HES PACS SLNO BRZE WOOF CAR MIST YY SAND FE Mar 28, 2025 06:33AM
23andMe Holding Co. (ME) Halted on Volatility, Up 117% Mar 27, 2025 10:00AM
Increasing unusual option volume: DNB HUYA PRMB FE NAK WEN ALNY ME CG EPAM Mar 24, 2025 10:20AM


Mar 24, 2025 07:30AM 23andMe (ME) Initiates Voluntary Chapter 11 Process
Mar 21, 2025 07:30AM 23andMe (ME) Launches New Homocysteine Genetic Report and Accompanying Lab Test
Mar 3, 2025 04:36PM 23andMe (ME) Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
Mar 3, 2025 10:27AM Increasing unusual option volume: SNDX ALGM VNET RC HSBC ME ODFL DV LXRX EU BPMC
Jan 31, 2025 07:30AM 23andMe Holding Co. (ME) Launches New Genetic Report on Osteoporosis
Jan 29, 2025 02:09AM 23andMe Holding Co. (ME) Reports Q3 Loss of $1.02
Jan 28, 2025 05:26PM 23andMe Holding Co. (ME) to explore strategic alternatives, including possible sale
Jan 28, 2025 05:11PM 23andMe Holding Co. (ME) Halted, News Pending
Jan 17, 2025 02:18PM 23andMe (ME) quietly exploring a possible sale of its telehealth business, Lemonaid - Business Insider
Jan 8, 2025 07:33AM 23andMe (ME) Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
Nov 20, 2024 07:30AM 23andMe (ME) and Mirador Therapeutics Enter Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
Nov 12, 2024 07:45AM 23andMe Holding Co. (ME) Misses Q2 EPS by 216c
Oct 30, 2024 05:00PM 23andMe (ME) Regains Nasdaq Compliance
Oct 29, 2024 07:30AM 23andMe Holding Co. (ME) Appoints Andre Fernandez, Jim Frankola, and Mark Jensen to its Board
Oct 16, 2024 08:15AM 23andMe Holding Co. (ME) Completes 1:20 Reverse Share Split
Oct 11, 2024 08:15AM 23andMe Holding (ME) Announces 1:20 Reverse Share Split
Oct 8, 2024 07:00AM 23andMe Holding (ME) Appoints Mathew Knowles as Brand Ambassador
Sep 25, 2024 07:30AM 23andMe Holding Co. (ME) Launches New Genetic Report on Likelihood of Frequent Emotional Eating
Sep 18, 2024 04:48PM 23andMe Holding (ME) no longer in compliance with Nasdaq listing rules
Sep 17, 2024 04:26PM 23andMe Holding (ME) Announces Resignation of Independent Directors from Board
Sep 16, 2024 06:18AM 23andMe Holding Co. (ME) Reports Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
Sep 16, 2024 04:58AM Citi Reiterates Neutral Rating on 23andMe Holding (ME)
Sep 11, 2024 04:49PM 23andMe (ME) CEO Wojcicki Open To Considering Takeover Proposals - Bloomberg
Aug 28, 2024 07:32AM 23andMe (ME): Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
Aug 8, 2024 05:22PM 23andMe Holding Co. (ME) Tops Q1 EPS by 8c
Aug 2, 2024 08:01AM 23andMe Holding Co. (ME) Special Committee responds to CEO’s take-private proposal
Aug 1, 2024 08:00AM 23andMe Holding Co. (ME) Announces CEO’s $0.40/sh Take-Private Proposal
Jun 28, 2024 07:17AM 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
Jun 10, 2024 10:01AM ICO to investigate 23andMe data breach with Canadian counterpart